Slingshot members are tracking this event:
AbbVie (ABBV) Phase 2 Data Evaluating ABT-494 in Crohn's Disease Expected in H1 2017
Slingshot Insights Explained
May 09, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 2, Abt-494, Crohn's Disease